With the exception of one placebo patient without valid data during the treatment phase, all patients (acarbose n = 240; placebo n = 119) were included in the safety and efficacy analyses.

In this PMS study with acarbose, patients showed the typical characteristics of type 2 diabetes patients (e.g. mean age 64 years, BMI 29.0 kg/m 2, 76.1% had cardiovascular diseases). Three ...